Related Experiment Video
Updated: Oct 9, 2025

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
Association of androgenetic alopecia and severity of coronavirus disease 2019
Rabia Ghafoor1, Syeda Mahanum Ali1, Anant Patil2
1Department of Dermatology, Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
Insights
Androgenetic alopecia (AGA) is more frequent and severe in men with worse COVID-19 outcomes. Severe AGA in younger men, even without comorbidities, indicates potential benefit from anti-androgen drugs for COVID-19 treatment.
Area of Science:
- Dermatology
- Infectious Diseases
- Endocrinology
Background:
- Androgenetic alopecia (AGA) is a common condition affecting both men and women.
- The severity of coronavirus disease 2019 (COVID-19) can vary significantly among patients.
- Understanding potential risk factors and associations for severe COVID-19 is crucial for patient management.
Purpose of the Study:
- To investigate the association between the severity of androgenetic alopecia (AGA) and the clinical outcomes of coronavirus disease 2019 (COVID-19).
- To compare the prevalence and severity of AGA in male and female COVID-19 patients.
- To explore potential therapeutic implications based on observed associations.
Main Methods:
- An observational study was conducted with 300 hospitalized COVID-19 patients.
- Patients were assessed for the presence and severity of androgenetic alopecia using standardized scales (Hamilton-Norwood for men, Ludwig for women).
- COVID-19 severity was categorized based on hospital outcomes, and correlations with AGA severity were analyzed.
Main Results:
- A higher frequency and severity of AGA were observed in male COVID-19 patients (80.55% with severe AGA) compared to females (46% with AGA).
- Males with severe AGA showed significantly worse COVID-19 outcomes (p<0.000) compared to females (p=0.273).
- Younger male patients with severe AGA, even without comorbidities, experienced adverse COVID-19 outcomes.
Conclusions:
- There is a significant association between the severity of androgenetic alopecia and worse hospital outcomes in men with COVID-19.
- The findings suggest that AGA may be a risk factor for severe COVID-19, particularly in men.
- The study supports the hypothesis that anti-androgen therapies could be a potential treatment strategy for COVID-19 patients, especially those with severe AGA.
Objective:
To establish the association of androgenetic alopecia (AGA) and the severity of coronavirus disease 2019 (COVID-19).
Design:
Observational study.
Methodology:
A total of 300 hospitalized patients of COVID-19 were included. Scoring of AGA was done, and severity of COVID-19 was measured as better and worse hospital outcomes. Correlation between severity of AGA and severity of COVID-19 was noted.
Results:
Out of 300 patients, 220 (73.33%) were male and 80 (26.67%) were female. In males, mild-to-moderate Hamilton-Norwood scale (HNS<3) and severe alopecia (HNS3-7) were noted among 43(20%) and 177(80.55%) patients, respectively. In females, 43(54%) had no AGA while 37(46%) had AGA. In 37 females with AGA, mild-to-moderate (Ludwig scale <2) and severe alopecia (Ludwig scale 2-3) were seen in 9(24.32%) and 28(75.68%) patients, respectively. We report a significant increase in frequency (95%) and severity of AGA and worse outcomes in males (p-value 0.000, chi-square: 18.90) compared with females (46%) (p-value 0.273, chi-square: 7.544), with notable adverse COVID-19 disease outcomes in the younger age group of men and also in few women of younger age group suffering from AGA without any comorbidities.
Conclusion:
Our study shows a significant increase in frequency and severity of AGA and worse outcomes in men compared with women. There was a significant association between AGA severity and hospital disease outcome in men compared with women. Younger age group patients with severe AGA particularly men also faced adverse outcomes while having no known comorbidities, supporting the hypothesis that anti-androgen drugs might be valuable in patients of COVID-19.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...
Psychoneuroimmunology: Diabetes and Cancer
Factors Affecting Illness
For instance, risk factors are connected to illness,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Coronary Artery Disease I: Introduction

